BlackRock Fund Advisors - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 122 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$36,211,000
+36.8%
2,270,297
+42.7%
0.01%
+40.0%
Q3 2016$26,476,000
+56.0%
1,591,102
+4.9%
0.01%
+25.0%
Q2 2016$16,975,000
+23.7%
1,517,007
-7.6%
0.00%
+33.3%
Q1 2016$13,728,000
-9.1%
1,642,070
+1.2%
0.00%0.0%
Q4 2015$15,109,000
-20.5%
1,622,846
-3.7%
0.00%
-40.0%
Q3 2015$19,004,000
-8.8%
1,684,784
+2.6%
0.01%0.0%
Q2 2015$20,833,000
+50.8%
1,641,711
+10.5%
0.01%
+66.7%
Q1 2015$13,812,000
-37.9%
1,485,191
-4.4%
0.00%
-40.0%
Q4 2014$22,243,000
+74.3%
1,553,289
+26.3%
0.01%
+25.0%
Q3 2014$12,763,000
-36.6%
1,229,530
-1.2%
0.00%
-33.3%
Q2 2014$20,133,000
-7.3%
1,244,343
-6.9%
0.01%0.0%
Q1 2014$21,711,000
+36.8%
1,336,039
+4.5%
0.01%
+20.0%
Q4 2013$15,873,000
+11.5%
1,279,081
-1.6%
0.01%0.0%
Q3 2013$14,236,000
+81.9%
1,300,131
+34.2%
0.01%
+66.7%
Q2 2013$7,825,000968,5010.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,658,759$121,733,0008.95%
Palo Alto Investors LP 4,155,670$108,588,0005.78%
Stonepine Capital Management, LLC 220,848$5,771,0005.07%
Birchview Capital, LP 80,000$2,090,0001.98%
EAM Global Investors LLC 75,310$1,968,0001.08%
Atika Capital Management LLC 130,000$3,397,0001.00%
EAM Investors, LLC 110,806$2,895,0000.79%
UNIVERSITY OF NOTRE DAME DU LAC 97,521$2,548,0000.62%
ALGERT GLOBAL LLC 76,204$1,991,0000.56%
361 CAPITAL LLC 85,885$2,244,0000.46%
View complete list of VANDA PHARMACEUTICALS INC shareholders